Stock Information
Moderna Inc (MRNA)
Ticker Symbol: MRNA
Exchange: NASDAQ
Sector: N/A
Market Cap: $13,345.44 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -7.2617
Revenue (TTM): $4.96 M
Dividend Yield: N/A%
ROE: -30.15%
Latest News
-
FDA reversal on mRNA-1010 could transform the seasonal influenza vaccines market
Wed, Feb 25, 2026 4:08 PM
-
3 Reasons to Avoid MRNA and 1 Stock to Buy Instead
Wed, Feb 25, 2026 2:21 PM
-
Moderna's Ups and Downs: Here's What You Need to Know Before Investing.
Wed, Feb 25, 2026 1:35 PM
-
A Fresh Look At Moderna (MRNA) Valuation After A Sharp Share Price Rebound
Wed, Feb 25, 2026 8:13 AM
-
What the Options Market Tells Us About Moderna
Tue, Feb 24, 2026 4:00 PM
-
Will the FDA yank mRNA vaccines?
Tue, Feb 24, 2026 7:52 AM
-
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
Mon, Feb 23, 2026 9:01 PM
-
Tectonic Therapeutic Appoints Independent Director Of Moderna François Nader To Independent Director And Chair Of Company Board Effective April 1st
Mon, Feb 23, 2026 5:06 PM
-
Here's Why I Wouldn't Touch Moderna With a 10‑Foot Pole Until Its Next Growth Engine Is Clear
Mon, Feb 23, 2026 2:20 PM
-
Moderna Stock Is Trading Higher Today: What's Going On?
Mon, Feb 23, 2026 1:50 PM
Key Financials
Financial data not available